Veterinary Biomarkers Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The global veterinary biomarkers market encompasses measurable biological indicators used to assess health status, monitor disease progression, and guide therapeutic decisions in animals. Valued at roughly $0.91 billion in 2025, the market is on a trajectory to reach approximately $1.61 billion by 2030. Biomarkers play a critical role in veterinary diagnostics, which is itself a much larger market estimated at over $3.6 billion in 2025.

• •The market is projected to grow at a 12 percent annual rate through 2030
• •Veterinary biomarkers serve companion animals, livestock, and other animals in clinical and research settings
• •No official government statistical agencies publish dedicated market size figures for this sector

Several factors are fueling expansion across the veterinary biomarkers market. Rising pet ownership and the humanization of companion animals have increased spending on advanced veterinary healthcare, while livestock producers increasingly rely on diagnostic tools to maintain herd health and productivity. Meanwhile, advances in molecular biology and immunoassay technologies have made biomarker-based testing more accessible and informative for veterinarians.

• •Growing companion animal population and increased pet care expenditure in developed and emerging markets
• •Rising demand for precision and personalized veterinary medicine
• •Technological advancements in genomics, proteomics, and point-of-care diagnostic platforms

The market is typically segmented by animal type, biomarker type, application, and technology platform. Companion animals, especially dogs and cats, represent the largest segment due to strong demand in North America and Europe. Regional analysis shows North America as the dominant market, with the U.S. veterinary biomarkers segment alone expected to reach roughly $717 million by 2030.

• •North America holds the largest market share, supported by advanced veterinary infrastructure and high pet ownership rates
• •Asia-Pacific and Latin America are emerging as high-growth regions due to rising companion animal adoption
• •The U.S. market alone is forecasted to reach approximately $717 million by 2030

What are the recent trends and outlook?

Several emerging trends are expected to shape the market over the next five years. The adoption of point-of-care testing in veterinary clinics is accelerating, enabling faster on-site biomarker analysis. Additionally, the integration of artificial intelligence with biomarker data is opening new possibilities for predictive health monitoring and early disease detection in animals.

• •Point-of-care diagnostic devices are gaining traction in general and specialty veterinary practices
• •Artificial intelligence and machine learning tools are being applied to interpret biomarker profiles for predictive analytics
• •The broader biomarkers market, valued at nearly $87 billion in 2025, provides a technology and investment backdrop for veterinary-specific innovation